A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2009
12/10/2009	WO2009147665A1 Process for manufacture of a medicament with granulation and pan coating
12/10/2009	WO2009147492A2 Radiologic marker
12/10/2009	WO2009147387A1 A transdermal drug delivery device
12/10/2009	WO2009147372A2 Drug delivery composition
12/10/2009	WO2009147269A1 Topical ibuprofen formulation
12/10/2009	WO2009147238A1 Solid pharmaceutical formulations comprising bibw 2992
12/10/2009	WO2009147220A1 Pharmaceutical dosage form for immediate release of an indolinone derivative
12/10/2009	WO2009147212A1 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
12/10/2009	WO2009147173A1 Vaginal suppository comprising lactic acid
12/10/2009	WO2009147144A2 Composition comprising an antibiotic and a corticosteroid
12/10/2009	WO2009147119A1 Capsule with organic/inorganic hybrid wall
12/10/2009	WO2009146929A1 Stimuli-responsive hydrogel
12/10/2009	WO2009146852A1 A topical composition comprising the isolated non-polar lipid fraction of lan0lin4
12/10/2009	WO2009146803A1 Fully synthetic albumin analogue
12/10/2009	WO2009146779A1 Stable crystal modifications of dopc
12/10/2009	WO2009146537A1 Multilayer control-release drug delivery system
12/10/2009	WO2009146523A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
12/10/2009	WO2009129531A3 Bupivacaine formulation in a polyorthoester carrier
12/10/2009	WO2009129527A3 Baclofen formulation in a polyorthoester carrier
12/10/2009	WO2009129476A3 An antibody bound synthetic vesicle containing active agent molecules
12/10/2009	WO2009129149A3 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
12/10/2009	WO2009129147A3 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
12/10/2009	WO2009128075A4 Plaster with medication dispenser
12/10/2009	WO2009127922A3 Pharmaceutical formulation for treating cardiovascular disease
12/10/2009	WO2009126950A3 Diterpene glycosides as natural solubilizers
12/10/2009	WO2009126682A3 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
12/10/2009	WO2009125981A3 Pharmaceutical formulation
12/10/2009	WO2009120484A3 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
12/10/2009	WO2009118754A3 A process for preparing a stable lyophilized composition
12/10/2009	WO2009117401A8 Compositions for site-specific delivery of imatinib and methods of use
12/10/2009	WO2009116880A3 Process for obtaining powder compositions of orlistat to be filled into a capsule
12/10/2009	WO2009116086A3 Topical formulation comprising adapalene microspheres and clindamycin
12/10/2009	WO2009114685A3 O-desmethylvenlafaxine salts
12/10/2009	WO2009109990A3 Pramipexole composition comprising sugar alcohol(s)
12/10/2009	WO2009108760A3 Dendritic macroporous hydrogels prepared by crystal templating
12/10/2009	WO2009097443A3 Liquid formulations of compounds active at sulfonylurea receptors
12/10/2009	WO2009069089A9 Levetiracetam controlled release composition
12/10/2009	WO2009026257A8 Methods and compositions for controlling the bioavailability of poorly soluble drugs
12/10/2009	WO2009019498A3 Improvements relating to skin dressings
12/10/2009	WO2008149338A3 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
12/10/2009	WO2008124814A3 Sublingual formulations of d-cycloserine and methods of using same
12/10/2009	WO2005075663A3 Nanosized composite material containing a biological compound and process for the preparation
12/10/2009	US20090306707 Joining and/or Sealing Tissues Through Photo-Activated Cross-Linking of Matrix Proteins
12/10/2009	US20090306632 Medicament delivery system and process
12/10/2009	US20090306571 Pressure Sensitive Adhesive Composition Comprising Cross-Linked Polyalkylene Oxide and Water Absorbent Hydrophilic Agents
12/10/2009	US20090306226 Procedures for obtaining polymers derived from vinyl acetate and their uses
12/10/2009	US20090306113 Pharmaceutical formulation
12/10/2009	US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/10/2009	US20090306012 Therapeutic protocols
12/10/2009	US20090304824 Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same
12/10/2009	US20090304806 Pharmaceutical Compositions
12/10/2009	US20090304805 Combinations and modes of administration of therapeutic agents and combination therapy
12/10/2009	US20090304804 Biologic devices for hemostasis
12/10/2009	US20090304803 Compositions and methods relating to target-specific photodynamic therapy
12/10/2009	US20090304802 Nasal delivery
12/10/2009	US20090304801 Aerosol and injectable formulations of nanoparticulate benzodiazepine
12/10/2009	US20090304800 Dry Coating using Twin-Screw Kneader
12/10/2009	US20090304799 Nanoemulsion influenza vaccine
12/10/2009	US20090304798 Methods and compositions for therapeutic use of RNA interference
12/10/2009	US20090304797 Process for the Preparation of Micronized Valsartan
12/10/2009	US20090304796 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
12/10/2009	US20090304795 Tablets with improved drug substance dispersibility
12/10/2009	US20090304794 Controlled release formulations of pramipexole
12/10/2009	US20090304793 Sustained release opioid formulations and methods of use
12/10/2009	US20090304792 Granule and orally disintegrating tablet comprising oxycodone
12/10/2009	US20090304791 Solid oral forms of ebastine
12/10/2009	US20090304790 Controlled release pharmaceutical compositions comprising a fumaric acid ester
12/10/2009	US20090304789 Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
12/10/2009	US20090304788 Encapsulated materials and methods for encapsulating materials
12/10/2009	US20090304787 Drug delivery composition
12/10/2009	US20090304786 Stable Dosage Forms of an Antidepressant
12/10/2009	US20090304785 Escalating dosing regimen for effecting weight loss and treating obesity
12/10/2009	US20090304784 Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component
12/10/2009	US20090304783 Compositions and methods for treating bacteria
12/10/2009	US20090304782 Topical Ibuprofen Formulation
12/10/2009	US20090304781 Master gene of arteriogenesis
12/10/2009	US20090304780 Wound dressings incorporating honey
12/10/2009	US20090304779 Micro-membrane implant with cusped opening
12/10/2009	US20090304778 Diagnostics and Methods for Removal and Detection of Interferents
12/10/2009	US20090304777 Agent administration
12/10/2009	US20090304776 Transmucosal delivery of therapeutic agents and methods of use thereof
12/10/2009	US20090304775 Drug-Exuding Orthopedic Implant
12/10/2009	US20090304765 R-ras activity in vascular regulation
12/10/2009	US20090304758 Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
12/10/2009	US20090304756 Method for the Encapsulation and Controlled Release of Poorly Water-Soluble (Hyprophobic) Liquid and Solid Active Ingredients
12/10/2009	US20090304755 Pharmaceutical formulation of losartan
12/10/2009	US20090304754 Pegylated glutenase polypeptides
12/10/2009	US20090304753 Method and Apparatus For Forming Delivery Devices For Oral Intake of an Agent
12/10/2009	US20090304748 Clostridial toxin pharmaceutical compositions
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304723 Mono-and disaccharide derivatives
12/10/2009	US20090304605 Substituted Aminothiazole Prodrugs of Compounds with Anti-HCV Activity
12/10/2009	US20090304604 Pulmonary delivery of alpha-1 proteinase inhibitor
12/10/2009	US20090304602 Nutritional supplement
12/10/2009	US20090304599 Protein Nanoparticles and the Use of the Same
12/10/2009	US20090304589 Radiation sensitive liposomes
12/10/2009	US20090304576 Device for delivery of anti-cancer agents to tissue
12/10/2009	CA2727088A1 Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same
12/10/2009	CA2726949A1 Stimuli-responsive hydrogel
12/10/2009	CA2726890A1 Creamy o/w emulsion composition and production process thereof

1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 2991